One-year results from the REDUCER-I multi-center real-world clinical trial of the treatment of refractory angina with the coronary sinus Reducer

Back

ESC Professional Premium Access

One-year results from the REDUCER-I multi-center real-world clinical trial of the treatment of refractory angina with the coronary sinus Reducer

Session: Outcomes in coronary artery disease

Topic: Treatment

Speaker: Professor S. Verheye (Antwerp, BE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Stefan Verheye

ZNA Middelheim Hospital, Antwerp (Belgium)

0 follower

5 more presentations in this session

Correlation between short-term quality of life improvement and clinical outcomes - a post-hoc ISCHEMIA trial analysis

Speaker: Doctor T. Caldonazo (Jena, DE)

Outcomes by race and ethnicity in patients undergoing percutaneous coronary intervention of chronic total occlusion

Speaker: Doctor M. Petrovic (New York, US)

Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in the ISCHEMIA trial

Speaker: Doctor A. Singh (Los Angeles, US)

Multi-modality deep learning model for prediction of chronic obstructive coronary artery disease

Speaker: Doctor R. Trivedi (Los Angeles, US)

Relationship between coronary artery calcium score and plaque vulnerability in patients with established coronary artery disease

Speaker: Mr D. Fujimoto (Boston, US)

Access the full session

Outcomes in coronary artery disease

Speakers: Professor S. Verheye, Doctor T. Caldonazo, Doctor M. Petrovic, Doctor A. Singh, Doctor R. Trivedi...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources